Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel PK-guided Dosing in NSCLC
NCT02737709Phase 2Terminated
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2016
- Primary completion
- Oct 2018
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Started Mar 2016; status: terminated.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02737709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737709.